Skip to content

Clinical trials

Phase 3 Stroke trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: South Korea Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20053
20062
20071
20082
20091
20102
20113
20124
20136
20142
20171
20184
20191
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated7
Unknown status3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Bayer3
Novartis Pharmaceuticals3
Allergan2
Boehringer Ingelheim2
Pfizer2
Samsung Medical Center2
Sanofi2
Boryung Pharmaceutical Co., Ltd1
CSL Behring1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke35
Myocardial Infarction10
Cardiovascular Diseases8
Ischemic Stroke8
Atrial Fibrillation5
Heart Diseases4
Ischemic Attack, Transient4
Muscle Spasticity4
Acute Coronary Syndrome3
Cerebrovascular Disorders3

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.